Recruiting Ankylosing Spondylitis Studies in Rio De Janeiro
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis
An 18-month double-blind, randomized, placebo-controlled, multicenter, Phase 3 study to evaluate the safety and efficacy of oral nizubaglustat (AZ-3102) in late-infantile and juvenile forms of Niemann...
A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.
This study is to investigate the ability of LXE408 to reduce or remove the level of parasites in the blood of people with chronic Chagas disease. Participants must have chronic Chagas disease without ...
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC)
An 18-month double-blind, randomized, placebo-controlled, multicenter, Phase 3 study to evaluate the safety and efficacy of oral nizubaglustat (AZ-3102) in late-infantile and juvenile forms of Niemann...
About Ankylosing Spondylitis Clinical Trials in Rio De Janeiro
Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.
There are currently 3 ankylosing spondylitis clinical trials recruiting participants in Rio De Janeiro, RIO%20DE%20JANEIRO. These studies are seeking a combined 349 participants. Research is being sponsored by Azafaros A.G., Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Ankylosing Spondylitis Clinical Trials in Rio De Janeiro — FAQ
Are there ankylosing spondylitis clinical trials in Rio De Janeiro?
Yes, there are 3 ankylosing spondylitis clinical trials currently recruiting in Rio De Janeiro, RIO%20DE%20JANEIRO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Rio De Janeiro?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rio De Janeiro research site will contact you about next steps.
Are clinical trials in Rio De Janeiro free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rio De Janeiro studies also compensate for your time and travel.
What ankylosing spondylitis treatments are being tested?
The 3 active trials in Rio De Janeiro are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.
Data updated March 2, 2026 from ClinicalTrials.gov